What drugs can't patients with thyroid cancer use

Clinically, patients with thyroid cancer cannot use estrogen-containing drugs, antithyroid drugs, antiarrhythmic drugs, liver-protecting drugs, etc. When taking medication, detailed examinations are required to clarify the specific situation before taking the medication to avoid affecting physical health.

1. Estrogen-containing drugs: Patients with thyroid cancer should not use estrogen-containing drugs, such as compound estradiol valerate tablets, nialstradiol tablets, etc. The above drugs may increase estrogen in the body, and hormone stimulation may cause thyroid cancer to worsen;

2. Antithyroid drugs: Common antithyroid drugs include propylthiouracil tablets, methimazole tablets, etc. If the patient suffers from thyroid cancer, the use of antithyroid drugs can inhibit the synthesis of thyroid hormones and may also cause the thyroid cancer to worsen;

3. Antiarrhythmic drugs: such as propafenone hydrochloride tablets, propranolol hydrochloride tablets, etc., because antiarrhythmic drugs can also inhibit the cardiac pacemaker or make the heart beat too slowly, thus causing bradycardia in thyroid cancer patients and affecting their health;

4. Liver protection drugs: such as compound glycyrrhizic acid tablets, glutathione tablets, etc. Since thyroid cancer patients may suffer certain damage to the liver while taking anticancer drugs, and liver protection drugs such as compound glycyrrhizic acid tablets and glutathione tablets have certain hepatotoxicity, which may aggravate liver damage after use, so thyroid cancer patients should avoid using liver protection drugs;.

In addition, thyroid cancer patients should not use androgen drugs because androgens can stimulate the growth and proliferation of cancer cells, thereby accelerating the spread and metastasis of cancer cells, which may cause thyroid cancer to worsen.